Skip to main content
Home
Issues
2024
November 2024 Vol 17, Payers' Guide to FDA Updates
2023
December 2023 Vol 16, Payers' Guide to FDA Updates
September 2023 Vol 16, Payers' Guide to FDA Updates
June 2023 - Vol 16 No 1
Issue Archive
Topics
Conference Correspondent
ESMO 2024 - Small Cell Lung Cancer
EHA 2024 – Wrap-Up: Myelodysplastic Syndrome
ASCO 2024 – Wrap-Up: Myelodysplastic Syndrome
Multimedia
Videos
Interview with the Innovators
Editorial Board
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Process
Advertising Policy
Subscribe
Home
Issues
2024
November 2024 Vol 17, Payers' Guide to FDA Updates
2023
December 2023 Vol 16, Payers' Guide to FDA Updates
September 2023 Vol 16, Payers' Guide to FDA Updates
June 2023 - Vol 16 No 1
Issue Archive
Topics
Conference Correspondent
ESMO 2024 - Small Cell Lung Cancer
EHA 2024 – Wrap-Up: Myelodysplastic Syndrome
ASCO 2024 – Wrap-Up: Myelodysplastic Syndrome
Multimedia
Videos
Interview with the Innovators
Editorial Board
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Process
Advertising Policy
Oncology
Leukemia
,
Oncology
Umbralisib plus Ublituximab Combination Superior to Chemoimmunotherapy in Patients with Chronic Lymphocytic Leukemia
Wayne Kuznar
Wayne Kuznar
Read More
Leukemia
,
Oncology
First-Line Fixed-Duration Ibrutinib plus Venetoclax Therapy Leads to Deep Remissions in Patients with Chronic Lymphocytic Leukemia
Phoebe Starr
Phoebe Starr
Read More
Leukemia
,
Oncology
Oral Azacitidine Extends Survival in Acute Myeloid Leukemia, Regardless of MRD Status, in Patients in Remission After Chemotherapy
Wayne Kuznar
Wayne Kuznar
Read More
FDA Approvals
,
Multiple Myeloma
,
Oncology
Xpovio Approved for Patients with Relapsed or Refractory Multiple Myeloma
Read More
FDA Approvals
,
Lung Cancer
,
Oncology
Tagrisso Approved as Adjuvant Therapy for NSCLC with EGFR Mutations
Read More
Multiple Myeloma
,
Oncology
Belantamab Induces Deep Responses in Heavily Pretreated Patients with Relapsed or Refractory Multiple Myeloma
Wayne Kuznar
Wayne Kuznar
Read More
Leukemia
,
Oncology
Asciminib, First-in-Class STAMP Inhibitor, Superior to Bosutinib in Chronic-Phase CML
Phoebe Starr
Phoebe Starr
Read More
Multiple Myeloma
,
Oncology
,
Bispecific Antibodies
Bispecific Antibodies in Phase 1 Studies Show Promising Efficacy in Heavily Pretreated Patients with Multiple Myeloma
Wayne Kuznar
Wayne Kuznar
Read More
FDA Approvals
,
Leukemia
,
Oncology
Oral Onureg First Drug Approved for Adults with AML in Remission
Read More
Disparities in Cancer Care
,
Oncology
AACR’s Cancer Disparities Inaugural Report Addresses Care Inequities
Wayne Kuznar, Medical Writer
Wayne Kuznar
Read More
1
2
3
4
5
6
7
Page 4 of 27
Results 31 - 40 of 262